After buying Morpeth custom manufacturing website (previously belonging to Pfizer Inc.), NPIL Pharma has becomes one of the leading custom manufacturing companies all over the world.
Morpeth website is integrated website of API & Formulations with increasing capabilities for commercial manufacturing. The website creates a number of completed APIs and uses unique technologies in compositions. Morpeth website on a constant basis supplies more than 300 finished dosage forms SKUs (stock keeping units) to more than 100 pharmaceutical markets, US, Europe and Japan included.
NPIL Pharma owns assets across North America, UK and India, and offers creation and commercial scale manufacture services concerning both API and Formulations.
Early-phase business is called PDS (Pharma Development and Scale-up) while late-phase offerings are generally called PMS (Pharma Manufacturing Services). Generic medications, intermediates and vitamins business are gathered under Manufactured Molecules/ Building Blocks (MM/BB).
PDS segment includes PDS API business which is led by Torcan in North America with a number of kilo labs and pilot plants in the US, Europe and India. PDS Formulations activities are performed at development labs and pilot plants in Mumbai and UK.
PMS segment also includes PMS API business which is maintained by capabilities of technology in chiral synthesis, bio-transformations and in handling High Potency Substances outside the UK and India. PMS Formulations services are offered from the websites in the UK and India.